{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03142204",
            "orgStudyIdInfo": {
                "id": "14-14488"
            },
            "organization": {
                "fullName": "CellSight Technologies, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy",
            "officialTitle": "Study of the Kinetics, Dosimetry and Safety of [18F]F-AraG (VisAcT), a Positron Emission Tomography Tracer for Imaging the Activation of the Immune System in Cancer Patients Who Have Received or Are Expected to Receive Immunotherapy and/or Radiation Therapy",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "farag-pet-imaging-for-analysis-of-biodistribution-in-cancer-patients-expected-to-undergo-immunotherapy-and-or-radiation-therapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-05-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-05-01",
            "studyFirstSubmitQcDate": "2017-05-03",
            "studyFirstPostDateStruct": {
                "date": "2017-05-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-12-01",
            "lastUpdatePostDateStruct": {
                "date": "2022-12-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "CellSight Technologies, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "UCSF Imaging Center at China Basin",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 1 study is to visualize biodistribution of a PET tracer called \\[18F\\]F-AraG (VisAcT) in cancer patients expected to undergo immunotherapy and/or radiation therapy.",
            "detailedDescription": "This is an exploratory Phase 1, prospective study assessing the biodistribution and radiation dosimetry of the Positron Emission Tomography \\[18F\\]FAraG (VisAcT) in cancer patients selected for immunotherapy and/or radiation therapy. Each patient may have up to two \\[ 18F\\]FAraG PET imaging sessions, a baseline scan and a post start of immunotherapy scan. For each imaging session, patients will receive a single injection of \\[18F\\]FAraG and undergo a whole-body PET scans an hour after injection of the tracer. Following each imaging session, the patient will be called within 72 hours to note any side effects.\n\nOptional - Blood samples may be collected at up to 9 time points post-injection to analyze whole-blood/plasma time activity of \\[18F\\]FAraG in addition an urine sample may be collected post scan."
        },
        "conditionsModule": {
            "conditions": [
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "[18F]F-AraG",
                    "description": "Single dose IV injection of \\[18F\\]F-AraG for each imaging day."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Visualize biodistribution of the PET tracer [18F]F-AraG pre-immunotherapy",
                    "description": "Whole-body \\[18F\\]F-AraG PET scan will be performed after intravenous injection of the PET tracer.consecutive time points the day of the intravenous injection of the PET tracer.",
                    "timeFrame": "Up to 6 weeks before immunotherapy is administered"
                },
                {
                    "measure": "Visualize biodistribution of the PET tracer [18F]F-AraG post start of immunotherapy",
                    "description": "Whole-body \\[18F\\]F-AraG PET scan will be performed after intravenous injection of the PET tracer.",
                    "timeFrame": "Up to 12 weeks after start of immunotherapy"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Cancer patients with identified tumor mass\n* Cancer patients expected to undergo immunotherapy and/or radiation therapy\n\nExclusion Criteria:\n\n* Under the age of 18\n* Pregnant women\n* Women who are breastfeeding\n* Individuals with known or suspected substance abuse\n* Individuals unable or unwilling to comply with the study procedures",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Robert R Flavell, M.D., Ph.D.",
                    "role": "CONTACT",
                    "phone": "917-509-8679",
                    "email": "robert.flavell@ucsf.edu"
                },
                {
                    "name": "Henry VanBrocklin, Ph.D.",
                    "role": "CONTACT",
                    "phone": "415-353-4569",
                    "email": "henry.vanbrocklin@radiology.ucsf.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Robert R Flavell, M.D., Ph.D.",
                    "affiliation": "UCSF Department of Radiology & Biomedical Imaging",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UCSF Imaging Center at China Basin",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maya Aslam",
                            "role": "CONTACT",
                            "phone": "415-514-8987",
                            "email": "maya.aslam@ucsf.edu"
                        },
                        {
                            "name": "Katherine Wu",
                            "role": "CONTACT",
                            "phone": "415-353-9437",
                            "email": "katherine.wu@ucsf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}